JPS5921684A - ３−アミノキヌクリジン誘導体、該誘導体の製法及び該誘導体を用いた治療上用の薬剤 - Google Patents

３−アミノキヌクリジン誘導体、該誘導体の製法及び該誘導体を用いた治療上用の薬剤

Info

Publication number
JPS5921684A
JPS5921684A JP58120912A JP12091283A JPS5921684A JP S5921684 A JPS5921684 A JP S5921684A JP 58120912 A JP58120912 A JP 58120912A JP 12091283 A JP12091283 A JP 12091283A JP S5921684 A JPS5921684 A JP S5921684A
Authority
JP
Japan
Prior art keywords
formula
group
compound
acid
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58120912A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0587516B2 (enExample
Inventor
テイエリ・インベル
ニコル・ドルメ
ミシエル・ラングロワ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of JPS5921684A publication Critical patent/JPS5921684A/ja
Publication of JPH0587516B2 publication Critical patent/JPH0587516B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP58120912A 1982-07-02 1983-07-02 ３−アミノキヌクリジン誘導体、該誘導体の製法及び該誘導体を用いた治療上用の薬剤 Granted JPS5921684A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8211670 1982-07-02
FR8211670A FR2529548A1 (fr) 1982-07-02 1982-07-02 Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique

Publications (2)

Publication Number Publication Date
JPS5921684A true JPS5921684A (ja) 1984-02-03
JPH0587516B2 JPH0587516B2 (enExample) 1993-12-16

Family

ID=9275643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58120912A Granted JPS5921684A (ja) 1982-07-02 1983-07-02 ３−アミノキヌクリジン誘導体、該誘導体の製法及び該誘導体を用いた治療上用の薬剤

Country Status (9)

Country Link
US (1) US4657911A (enExample)
EP (1) EP0099789B1 (enExample)
JP (1) JPS5921684A (enExample)
AU (1) AU562210B2 (enExample)
CA (1) CA1265802A (enExample)
DE (1) DE3372769D1 (enExample)
ES (1) ES8403897A1 (enExample)
FR (1) FR2529548A1 (enExample)
ZA (1) ZA834704B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228477A (ja) * 1984-04-06 1985-11-13 エイ・エイチ・ロビンス・カンパニー・インコーポレーテッド ２‐アルコキシ‐ｎ‐（１‐アザビシクロ［２，２，２］オクト‐３‐イル）ベンズアミド類およびチオベンズアミド類
JPS61183286A (ja) * 1985-02-04 1986-08-15 エイ・エイチ・ロビンス・カンパニー・インコーポレーテッド ２‐アルコキシ‐ｎ‐（１‐アザビシクロ〔２，２，２〕オクタン‐３‐イル）アミノベンズアミドの製法
JPS63196583A (ja) * 1987-02-04 1988-08-15 デララーンド　ソシエテ　アノニム ３―アミノキヌクリジンの絶対配置ｓ又はｒを持つ鏡像異性体の製法
JPH01199969A (ja) * 1987-10-16 1989-08-11 Delalande Sa 不安解消性化合物

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
JPS5936675A (ja) * 1982-07-13 1984-02-28 サンド・アクチエンゲゼルシヤフト 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
US5175173A (en) * 1983-12-22 1992-12-29 Sun Jung Hui Carboxamides useful as antiemetic or antipsychotic agents
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
US4722834A (en) * 1986-03-05 1988-02-02 A. H. Robins Company, Incorporated Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
EP0272052B1 (en) * 1986-12-16 1992-07-08 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Anxiolytic-N-(1-Azabicyclo[2.2.2]Oct-3-yl) Benzamides and Thobenzamides
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US5237066A (en) * 1987-02-04 1993-08-17 Delande S.A. Enantiomers of absolute configuration S of amide derivatives of 3-aminoquinuclidine, the process for preparing them and their application in therapy
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
FR2625678B1 (fr) * 1988-01-13 1991-06-07 Delalande Sa Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
US4863919A (en) * 1988-02-01 1989-09-05 A. H. Robins Company, Incorporated Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
US5290938A (en) * 1989-09-15 1994-03-01 Chiron Laboratories A.S. Preparation of S-(-)- and R-(+)-N-(quinuclidinyl-3)-amide
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
US5070095A (en) * 1990-12-12 1991-12-03 A. H. Robins Company, Incorporated Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and -4-amine as gastric prokinetic, antiemetic, and anxiolytic agents
GB9027487D0 (en) * 1990-12-19 1991-02-06 Beecham Group Plc Pharmaceuticals
US5084460A (en) * 1990-12-24 1992-01-28 A. H. Robins Company, Incorporated Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
US5138060A (en) * 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
FR2719842B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Sels quaternaires de dérivés de 1-azabicyclo [2.2.2] octane, leur préparation et leur application en thérapeutique.
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002016357A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
EP1381603A2 (en) 2000-08-18 2004-01-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
BR0212123A (pt) * 2001-08-24 2004-07-20 Upjohn Co 7-aza[2.2.1]biciclo-heptanos substituìdos com arila para o tratamento de doenças
MXPA04007936A (es) 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.
WO2003072578A1 (en) * 2002-02-20 2003-09-04 Pharmacia & Upjohn Company Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
JP2005537297A (ja) 2002-08-01 2005-12-08 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー アルファ−７ｎａｃｈｒ活性を有する１ｈ−ピラゾールおよび１ｈ−ピロール−アザビシクロ化合物
CN1914201A (zh) * 2003-12-22 2007-02-14 阿斯利康(瑞典)有限公司 烟碱乙酰胆碱受体配体
WO2008028903A2 (en) 2006-09-04 2008-03-13 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
WO2008119710A1 (en) * 2007-03-30 2008-10-09 Neurosearch A/S Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
PL2432467T3 (pl) 2009-05-20 2018-07-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Zastosowanie antagonistów receptora 5-ht3 serotoniny w leczeniu zaburzeń przedsionkowych ze zmianami chorobowymi
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5239681A (en) * 1975-09-25 1977-03-28 Ciba Geigy Ag Basiccsubstituted pyridine carbonic acid amide and acid addition product preparation method thereof and medical mixture containing these compounds
JPS5259128A (en) * 1975-11-03 1977-05-16 Thomae Gmbh Dr K Production of novel aminoo benzoic acid amide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE331841B (enExample) * 1967-05-23 1971-01-18 Astra Ab
US3534053A (en) * 1967-05-24 1970-10-13 American Home Prod Quinuclidine derivatives
US3702324A (en) * 1970-06-24 1972-11-07 Stanford Research Inst 3,4,5-trimethoxybenzamides of substituted anilines and of alkylpiperidines
FR2183565B1 (enExample) * 1972-05-10 1975-12-26 Cerm Cent Europ Rech Mauvernay
FR2329226A1 (fr) * 1975-11-03 1977-05-27 Ipa Ind Plastique Aquitain Porte-documents ou pochette
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5239681A (en) * 1975-09-25 1977-03-28 Ciba Geigy Ag Basiccsubstituted pyridine carbonic acid amide and acid addition product preparation method thereof and medical mixture containing these compounds
JPS5259128A (en) * 1975-11-03 1977-05-16 Thomae Gmbh Dr K Production of novel aminoo benzoic acid amide

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228477A (ja) * 1984-04-06 1985-11-13 エイ・エイチ・ロビンス・カンパニー・インコーポレーテッド ２‐アルコキシ‐ｎ‐（１‐アザビシクロ［２，２，２］オクト‐３‐イル）ベンズアミド類およびチオベンズアミド類
JPS61183286A (ja) * 1985-02-04 1986-08-15 エイ・エイチ・ロビンス・カンパニー・インコーポレーテッド ２‐アルコキシ‐ｎ‐（１‐アザビシクロ〔２，２，２〕オクタン‐３‐イル）アミノベンズアミドの製法
JPS63196583A (ja) * 1987-02-04 1988-08-15 デララーンド　ソシエテ　アノニム ３―アミノキヌクリジンの絶対配置ｓ又はｒを持つ鏡像異性体の製法
JPH01199969A (ja) * 1987-10-16 1989-08-11 Delalande Sa 不安解消性化合物

Also Published As

Publication number Publication date
DE3372769D1 (en) 1987-09-03
AU562210B2 (en) 1987-06-04
EP0099789B1 (fr) 1987-07-29
CA1265802A (en) 1990-02-13
US4657911A (en) 1987-04-14
FR2529548B1 (enExample) 1985-04-19
ES524128A0 (es) 1984-04-16
ES8403897A1 (es) 1984-04-16
AU1650783A (en) 1984-01-05
EP0099789A1 (fr) 1984-02-01
ZA834704B (en) 1984-03-28
JPH0587516B2 (enExample) 1993-12-16
FR2529548A1 (fr) 1984-01-06

Similar Documents

Publication Publication Date Title
JPS5921684A (ja) ３−アミノキヌクリジン誘導体、該誘導体の製法及び該誘導体を用いた治療上用の薬剤
CA2146259C (en) Substituted benzylaminoquinuclidines
US5741797A (en) Heteroatom substituted alkyl benzylaminoquinuclidines
JP4898062B2 (ja) アザ二環式カルバメートおよびアルファ−７ニコチン性アセチルコリンレセプターアゴニストとしてのその使用
EP0632809B1 (en) Quinuclidine derivatives as substance p antagonists
US5521220A (en) Acyclic ethylenediamine derivatives
JPH0363280A (ja) オキサジアゾール及びその塩類、痴呆を治療するそれらの用途、それらの製造法及び処方剤
JPH06504293A (ja) 抗虚血剤としての２−（４−ヒドロキシピペリジノ）−１−アルカノール誘導体
JP7262141B2 (ja) シャペロン介在性オートファジー調節剤として有用な化合物
JP4813357B2 (ja) Ｎ−ビアリールアミド化合物
US5604241A (en) Substituted benzylaminoquinuclidines as substance P antagonists
US5569662A (en) Quinuclidine derivatives as substance P antagonists
JPH04257579A (ja) ４−（２−フェニルエチル）ピペリジン−１−イル基をもつエタノールおよびエタノン誘導体、その製造および治療的応用
JPH0254832B2 (enExample)
JPS63196583A (ja) ３―アミノキヌクリジンの絶対配置ｓ又はｒを持つ鏡像異性体の製法
JPH01199969A (ja) 不安解消性化合物
JPH06507387A (ja) 新規な尿素およびチオ尿素類、その製造と治療への応用
US3903165A (en) Ethynylaryl amines and processes for their preparation
JPS6230986B2 (enExample)
JPS5939419B2 (ja) カテコ−ル誘導体の製造法
JPS62169784A (ja) ３−（アシルアミノメチル）イミダゾ〔１，２−ａ〕ピリジン誘導体、その製造法およびその医薬への応用
JPS5849344A (ja) 心臓血管系に対して作用する新規なフエノ−ルエ−テル、その製造方法、及び薬剤への使用
JPS6333383A (ja) 新規テトラヒドロベンゾチアゾ−ル−キノリン類、その製法及び用途
JPS5931493B2 (ja) カテコ−ル誘導体
JPS59116253A (ja) アルキルベンジリデン誘導体、その製造方法およびそれらを含有する医薬